Zealand Pharma is a biotech company that specializes in developing peptide-based medicines for metabolic and gastrointestinal diseases. With over 10 drug candidates in clinical development, Zealand’s pipeline is robust, including three candidates in late-stage development and one under regulatory review in the United States. The company’s flagship product is V-Go, an all-in-one insulin delivery option for diabetes patients. Zealand has also entered into collaboration agreements with Boehringer Ingelheim and Alexion Pharmaceuticals, expanding the reach of their peptide therapeutics.
Zealand Pharma's ticker is ZEAL
The company's shares trade on the NASDAQ stock exchange
They are based in Søborg, Denmark
There are 201-500 employees working at Zealand Pharma
It is zealandpharma.com
Zealand Pharma is in the Healthcare sector
Zealand Pharma is in the Biotechnology industry
The following five companies are Zealand Pharma's industry peers: